{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:05:15Z","timestamp":1771506315345,"version":"3.50.1"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Primary mucinous adenocarcinoma (PMAC) of the urethra is an exceptionally rare subtype of primary urethral carcinoma, with limited published data to guide diagnosis or treatment. Most literature consists of isolated case reports, and the non-specific presentation often delays diagnosis. This report presents two further cases and a review of the literature with a view to expand current understanding. We report two cases of PMAC. The first involves a 67-year-old male with progressive lower urinary tract symptoms initially treated as benign prostatic hyperplasia. Histology following a transurethral resection of the prostate revealed invasive mucinous adenocarcinoma with enteric features. He underwent radical prostatectomy, chemotherapy and radiotherapy for metastatic disease. The second case is a 52-year-old female with chronic urinary symptoms and a urethral mass initially misattributed to being from gynaecological origin. However, a biopsy later confirmed mucinous adenocarcinoma of the urethra. She underwent chemotherapy and radiotherapy, with partial response, but later developed further metastatic spread and is now undergoing palliative chemotherapy. PMAC is aggressive, often presents with non-specific urinary symptoms and lacks standardised diagnostic or treatment protocols. These cases highlight the importance of early detection through biopsies, immunohistochemical analysis and a multidisciplinary approach. Broader awareness and further reporting of cases are essential to develop evidence-based diagnostic and treatment guidelines for this rare malignancy.<\/jats:p>","DOI":"10.1177\/17562872261424118","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T02:45:17Z","timestamp":1771209917000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary mucinous adenocarcinoma of the urethra: a diagnostic conundrum \u2013 two case reports and literature review"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4469-1542","authenticated-orcid":false,"given":"Elspeth","family":"Jamieson","sequence":"first","affiliation":[{"name":"Darent Valley Hospital, Darenth Wood Road, Dartford, DA2 8DA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Goel","sequence":"additional","affiliation":[{"name":"Maidstone Hospital, Maidstone, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Lancaster","sequence":"additional","affiliation":[{"name":"Darent Valley Hospital, Dartford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Clarke","sequence":"additional","affiliation":[{"name":"Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-5613","authenticated-orcid":false,"given":"Sanjeev","family":"Madaan","sequence":"additional","affiliation":[{"name":"Darent Valley Hospital, Dartford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02550360"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.08.1057"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.10.031"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.4103\/UA.UA_136_17"},{"key":"e_1_3_4_6_2","volume-title":"Urinary and Male Genital Tumours. WHO Classification of Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. WHO Classification of Tumours, 5th ed., Vol. 8. Lyon (France): International Agency for Research on Cancer (IARC Press), 2022.","edition":"5"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.15118"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.12246"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318208f96a"},{"issue":"10","key":"e_1_3_4_10_2","article-title":"Primary mucinous cell adenocarcinoma of female urethra","volume":"15","author":"Banthia R","year":"2022","unstructured":"Banthia R, Singh UP, Danish N, et al. Primary mucinous cell adenocarcinoma of female urethra. BMJ Case Reports CP 2022; 15(10): e248507.","journal-title":"BMJ Case Reports CP"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000282925"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2024.109993"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010109"},{"issue":"2","key":"e_1_3_4_14_2","first-page":"564","article-title":"Rare pathology of primary urethral carcinoma","volume":"69","author":"Mani S","year":"2021","unstructured":"Mani S, Chowdry R, Dauchy EM. Rare pathology of primary urethral carcinoma. J Investig Med 2021; 69(2): 564\u2013565.","journal-title":"J Investig Med"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/iju5.12210"},{"key":"e_1_3_4_16_2","first-page":"159","article-title":"Mucinous adenocarcinoma of the Skene\u2019s gland-a case report","volume":"26","author":"Kimura N","year":"2019","unstructured":"Kimura N, Toki S, Fukuokaya W, et al. Mucinous adenocarcinoma of the Skene\u2019s gland-a case report. Int J Urol 2019; 26: 159.","journal-title":"Int J Urol"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.9738\/INTSURG-D-13-00073.1"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.886"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.2011.00911.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.1998.tb00606.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000001494"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2020.06.012"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.09.039"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.09.014"},{"issue":"4","key":"e_1_3_4_25_2","first-page":"267","article-title":"Mucinous adenocarcinoma of the male urethra: a report of two cases","volume":"37","author":"Raspollini MR","year":"2015","unstructured":"Raspollini MR, Carini M, Montironi R, et al. Mucinous adenocarcinoma of the male urethra: a report of two cases. Anal Quant Cytopathol Histpathol 2015; 37(4): 267\u2013272.","journal-title":"Anal Quant Cytopathol Histpathol"},{"key":"e_1_3_4_26_2","first-page":"135","article-title":"Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series","volume":"129","author":"Zhao T","year":"2022","unstructured":"Zhao T, Chuang HW, Cornejo KM, et al. Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series. Hum Pathol 2022; 129: 135\u2013142.","journal-title":"Hum Pathol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.11.023"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-012-0882-5"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105771"},{"issue":"7","key":"e_1_3_4_30_2","article-title":"Treatment of villous adenoma with underlying adenocarcinoma of the prostatic urethra using combined chemoradiation: a case report","volume":"16","author":"Corsi AJ","year":"2024","unstructured":"Corsi AJ, Bradley TP, Geetha SD, et al. Treatment of villous adenoma with underlying adenocarcinoma of the prostatic urethra using combined chemoradiation: a case report. Cureus 2024; 16(7): e64841.","journal-title":"Cureus"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-012-0882-5"}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872261424118","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562872261424118","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872261424118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:13:30Z","timestamp":1771503210000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562872261424118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"alternative-id":["10.1177\/17562872261424118"],"URL":"https:\/\/doi.org\/10.1177\/17562872261424118","relation":{},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"value":"1756-2872","type":"print"},{"value":"1756-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"article-number":"17562872261424118"}}